Results 11 to 20 of about 46 (42)

UEG Week 2018 Poster Presentations [PDF]

open access: yesUnited European Gastroenterol J, 2018
United European Gastroenterology Journal, Volume 6, Issue S8, Page A135-A747, October 2018.
europepmc   +2 more sources

UEG Week 2017 Poster Presentations [PDF]

open access: yesUnited European Gastroenterol J, 2017
United European Gastroenterology Journal, Volume 5, Issue S5, Page A161-A836, October 2017.
europepmc   +2 more sources

Finding balance between mature and immature neutrophils: The effects of empagliflozin in GSD‐Ib

open access: yes, 2023
eJHaem, Volume 4, Issue 2, Page 551-554, May 2023.
Fabiola Guerra   +10 more
wiley   +1 more source

Mimicking Intravasation–Extravasation with a 3D Glass Nanofluidic Model for the Chemotaxis‐Free Migration of Cancer Cells in Confined Spaces

open access: yesAdvanced Materials Technologies, Volume 5, Issue 11, November 2020., 2020
This work describes a novel approach to fabricating 3D glass nanofluidic devices with hierarchical architectures and narrow constrictive spaces for the observation of cancer cell migration in chemoattractant‐free environments. This device is used to demonstrate the capability of prostate cancer cells to penetrate two arrays of narrow constrictions ...
Felix Sima   +6 more
wiley   +1 more source

6th International Symposium on Molecular Allergology (ISMA)

open access: yesClinical and Translational Allergy, Volume 6, Issue S2, 18 October 2016., 2016
Table of contents ORAL ABSTRACTS Symposium 1: Biochemistry, structure and environment of the allergen: what makes a protein an allergen? O1 Two cell‐membrane peptidases carrying galactose‐alpha‐1,3‐galactose are implicated in delayed anaphylactic reactions upon pork kidney ingestion in patients with IgE‐antibodies to alpha‐Gal Christiane Hilger, Kyra ...
Christiane Hilger   +471 more
wiley   +1 more source

Physiologically based pharmacokinetic modeling of long‐acting extended‐release naltrexone in pregnant women with opioid use disorder

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 13, Issue 11, Page 1939-1952, November 2024.
Abstract Opioid use disorders (OUD) are a major issue in the U.S. Current treatments for pregnant women, like methadone and buprenorphine require daily dosing and have adverse effects. Monthly injectable naltrexone (XR‐NTX) mitigates these adverse effects but is not recommended during pregnancy due to limited pharmacokinetic and safety data. This study
Babajide Shenkoya   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy